日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

TBCRC 030 研究发现,循环肿瘤 DNA 与三阴性乳腺癌新辅助化疗后残余肿瘤负荷相关。

Parsons, H A; Blewett, T; Chu, X; Sridhar, S; Santos, K; Xiong, K; Abramson, V G; Patel, A; Cheng, J; Brufsky, A; Rhoades, J; Force, J; Liu, R; Traina, T A; Carey, L A; Rimawi, M F; Miller, K D; Stearns, V; Specht, J; Falkson, C; Burstein, H J; Wolff, A C; Winer, E P; Tayob, N; Krop, I E; Makrigiorgos, G M; Golub, T R; Mayer, E L; Adalsteinsson, V A

TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker

TBCRC 030:三阴性乳腺癌术前顺铂与紫杉醇的II期研究:评估同源重组缺陷(HRD)生物标志物

Mayer, E L; Abramson, V; Jankowitz, R; Falkson, C; Marcom, P K; Traina, T; Carey, L; Rimawi, M; Specht, J; Miller, K; Stearns, V; Tung, N; Perou, C; Richardson, A L; Componeschi, K; Trippa, L; Tan-Wasielewski, Z; Timms, K; Krop, I; Wolff, A C; Winer, E P

A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer

一种组合生物标志物可预测HER2阳性乳腺癌患者在接受新辅助拉帕替尼和曲妥珠单抗治疗(无需化疗)后达到病理完全缓解。

Veeraraghavan, J; De Angelis, C; Mao, R; Wang, T; Herrera, S; Pavlick, A C; Contreras, A; Nuciforo, P; Mayer, I A; Forero, A; Nanda, R; Goetz, M P; Chang, J C; Wolff, A C; Krop, I E; Fuqua, S A W; Prat, A; Hilsenbeck, S G; Weigelt, B; Reis-Filho, J S; Gutierrez, C; Osborne, C K; Rimawi, M F; Schiff, R

Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer.

绿茶提取物 Polyphenon E 对激素受体阴性乳腺癌女性生长因子信号传导系统生物标志物的影响

Crew K D, Ho K A, Brown P, Greenlee H, Bevers T B, Arun B, Sneige N, Hudis C, McArthur H L, Chang J, Rimawi M, Cornelison T L, Cardelli J, Santella R M, Wang A, Lippman S M, Hershman D L

Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up

一项对大量患者进行长期随访的研究中,三阴性乳腺癌的临床和生物学特征

Malorni, L; Shetty, P B; De Angelis, C; Hilsenbeck, S; Rimawi, M F; Elledge, R; Osborne, C K; De Placido, S; Arpino, G